Q4 2019 Holdings
Filed 2020-02-13 | 14 holdings | $314.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gossamer Bio(GOSS) | Common Stock | 38341P102 | $95.6K | 6,119,345 | 30.4% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $76.1K | 5,323,455 | 24.2% |
| Morphic Holding | Common Stock | 61775R105 | $51.0K | 2,969,582 | 16.2% |
| Translate Bio | Common Stock | 89374L104 | $19.8K | 2,437,603 | 6.3% |
| Immunic(IMUX) | Common Stock | 4525EP101 | $13.3K | 1,371,494 | 4.2% |
| Prevail Therapeutics | Common Stock | 74140Y101 | $10.6K | 668,907 | 3.4% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $10.5K | 2,600,410 | 3.3% |
| Essa Pharma(EPIEUR) | Common Stock | 29668H708 | $9.4K | 1,709,848 | 3.0% |
| Cidara Therapeutics | Common Stock | 171757107 | $6.3K | 1,640,514 | 2.0% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $5.6K | 130,646 | 1.8% |
| Trevi Therapeutics(TRVI) | Common Stock | 89532M101 | $4.7K | 1,263,408 | 1.5% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $4.6K | 529,965 | 1.5% |
| ObsEva | Common Stock | H5861P103 | $3.8K | 999,364 | 1.2% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $2.7K | 750,741 | 0.9% |